Bitter pill for Ranbaxy: SC notice on quality concerns

PIL also seeks action against drug regulator for letting a FDA-censured firm continue operations

pankaj

Pankaj Kumar | March 14, 2014



Ranbaxy faced another setback on Friday as the supreme court issued notice to the leading drugmaker as well as the central government following a PIL that seeks cancellation of the firm’s licence and a CBI probe into the allegedly sub-standard quality of its medicines.

"The matter requires consideration and we will examine it but we cannot grant any interim stay," a bench headed by chief justice P Sathasivam said.

The PIL was filed by advocate ML Sharma, pointing out that Ranbaxy was fined $500 million by the US Food and Drug Administration (USFDA) for making and selling adulterated drugs last year. The PIL demanded court to stop production from the manufacturing units in Paonta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh.

Read more about Ranbaxy’s travails:

Dirty medicine: Ranbaxy's FDA travails



Sharma sought action against the drug regulator, Central Drug Standards Control Organisation (CDSCO), for granting permission to Ranbaxy to sell drugs in India though the firm has faced a series of strictures from the US FDA.

Read interview with drug controller GN Singh:

"Ranbaxy has been asked to comply with regulations"

Comments

 

Other News

Wired for good: Building sustainable cities with AI

The First Industrial Revolution in the 18th-19th centuries ushered in a paradigm shift in how cities were imagined. Fueled by railways, factories and grids, and obsessed with speed and scale, it was an ode to efficiency, which spurred unprecedented economic growth. Now, as the Fourth Industrial Revolutio

How social media is reshaping elections

Since Brazil’s return to direct presidential elections in 1985, no candidate who finished second in the first round of polling had ever won the presidency. Luiz Inácio Lula da Silva, now 81, has just done it. What explains the comeback, and what changed in Brazilian politics to make it possi

Cabinet approves Dearness Allowance, Dearness Relief

The union cabinet chaired by prime minister Narendra Modi on Wednesday approved the release of an additional instalment of Dearness Allowance (DA) to central government employees and Dearness Relief (DR) to pensioners with effect from 01.07.2026 representing an increase of 3% over the existing rates of 6

Cyclone Arnab strikes Andhra as warming oceans amplify storm risks

Cyclone Arnab made landfall along the Andhra Pradesh and Yanam coasts in the early hours of Wednesday as a very severe cyclonic storm, with maximum sustained wind speeds of 125–135 kmph and gusts reaching 150 kmph. Its rapid intensification has raised concerns about how warmer oceans, global warmin

Counting matters but which ones?

The first instinct of public policy is to count. Its harder task is to count what counts. We have become remarkably good at measuring the reach of the welfare state vis-à-vis beneficiaries covered, rupees transferred, houses built, connections installed and services delivered. But some of the most

Inching closer to a trade deal with America

The cooperation between India and the United States goes back quite a time. We need to relegate that era to the backburner when Pandit Jawaharlal Nehru visited US in the times of president Dwight Eisenhower and called the American let-off of 10 million dollars in defence aid to Pakistan as a “gun w

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter